Clinical Trials in Boston

Showing 9381-9400 of 13,548 trials

Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

NCT00268918

The main purpose of this study is to see if the study drug, PTK787, is safe and to find the highest dose that can be given safely without causing serious side effects.

Ovarian CancerEndometrial CancerCervical Cancer+3 more

Dana-Farber Cancer Institute24 participantsStarted Sep 2005

Boston, Massachusetts, United States • Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

LED Therapy for the Treatment of Concussive Brain Injury

NCT02383472

A double blind randomized trial of light-emitting diode (LED) therapy for patients suffering from mild traumatic brain injury (mTBI). Patients seen in the Sports Concussion Clinic with cognitive symptoms lasting for greater than 4 weeks will be randomized to either placebo therapy (controls) or treatment with LED therapy (cases). Both cases and controls would complete post-concussion symptom scales Delis-Kaplan Executive Function System (D-KEFS), and ImPACT studies on entry into the study and at weeks 3 and 6, or earlier if their symptoms resolve before the end of the 6 week period.

Brain Concussion

Boston Children's Hospital53 participantsStarted Sep 2012

Boston, Massachusetts, United States • Waltham, Massachusetts, United States

Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

LED Therapy for the Treatment of Concussive Brain Injury

Find Trials by Condition in Boston

Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)

Brentuximab Vedotin for Steroid Refractory GvHD

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

Open Label Study of Long Term Safety Evaluation of Alirocumab

Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy

Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

TARGET Intracranial Aneurysm Coiling Registry

Intravenous Mepolizumab In Children With Eosinophilic Esophagitis

A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency

A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus

Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo

Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma